On July 20, 2026, during the World Artificial Intelligence Conference (WAIC2026), Insilico Medicine (HK3696) and Tencent Healthcare announced a deep strategic cooperation. The two sides will engage in in-depth collaboration in areas such as specialized model training in the life and health sector, high-performance computing, cloud-based ecological deployment, and commercial expansion, jointly exploring the boundaries of AI applications in the life sciences and promoting the industrialization and intelligent development of the entire new drug research and development process.
